Loading...
XAMSPHIA
Market cap23bUSD
Dec 20, Last price  
24.17EUR
1D
0.08%
1Q
-11.92%
Jan 2017
-14.96%
IPO
44.25%
Name

Koninklijke Philips NV

Chart & Performance

D1W1MN
XAMS:PHIA chart
P/E
—
P/S
1.24
EPS
—
Div Yield, %
0.01%
Shrs. gr., 5y
-0.80%
Rev. gr., 5y
0.05%
Revenues
18.17b
+1.92%
30,296,517,60030,371,519,32026,976,037,07026,835,349,62026,385,000,00023,189,000,00025,419,000,00022,579,000,00024,788,000,00023,329,000,00021,391,000,00024,244,000,00024,516,000,00017,780,000,00018,121,000,00019,482,000,00019,535,000,00017,156,000,00017,827,000,00018,169,000,000
Net income
-466m
L-71.20%
2,834,166,5602,866,432,4505,383,387,4504,174,890,690-92,000,000410,000,0001,446,000,000-1,295,000,000226,000,0001,169,000,000415,000,000645,000,0001,448,000,0001,657,000,0001,090,000,0001,168,000,0001,187,000,000612,000,000-1,618,000,000-466,000,000
CFO
2.26b
P
2,694,745,0402,088,822,940853,916,6301,368,310,6501,495,000,0001,545,000,0002,156,000,000566,000,0002,198,000,0001,138,000,0001,303,000,0001,167,000,0001,904,000,0001,870,000,0001,780,000,0002,031,000,0002,777,000,0001,629,000,000-173,000,0002,259,000,000
Dividend
May 09, 20240.9092 EUR/sh
Earnings
Jan 27, 2025

Profile

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
URL
https://www.philips.com/
IPO date
Sep 18, 2009
Employees
71,519
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
18,169,000
1.92%
17,827,000
3.91%
17,156,000
-12.18%
Cost of revenue
17,743,000
18,016,000
16,651,000
Unusual Expense (Income)
NOPBT
426,000
(189,000)
505,000
NOPBT Margin
2.34%
2.94%
Operating Taxes
(73,000)
(113,000)
(103,000)
Tax Rate
NOPAT
499,000
(76,000)
608,000
Net income
(466,000)
-71.20%
(1,618,000)
-364.38%
612,000
-48.44%
Dividends
(2,000)
(412,000)
(482,000)
Dividend yield
0.01%
3.34%
1.38%
Proceeds from repurchase of equity
(662,000)
(175,000)
(1,613,000)
BB yield
3.07%
1.42%
4.61%
Debt
Debt current
652,000
931,000
506,000
Long-term debt
7,823,000
8,352,000
7,693,000
Deferred revenue
515,000
446,000
Other long-term liabilities
2,099,000
1,595,000
2,035,000
Net debt
5,603,000
6,903,000
4,838,000
Cash flow
Cash from operating activities
2,259,000
(173,000)
1,629,000
CAPEX
(345,000)
(806,000)
(763,000)
Cash from investing activities
(636,000)
(1,487,000)
(3,672,000)
Cash from financing activities
(848,000)
500,000
(2,347,000)
FCF
1,882,000
(922,000)
841,000
Balance
Cash
1,872,000
1,183,000
2,305,000
Long term investments
1,000,000
1,197,000
1,056,000
Excess cash
1,963,550
1,488,650
2,503,200
Stockholders' equity
6,496,000
8,532,000
10,305,000
Invested Capital
19,807,450
22,065,350
21,302,800
ROIC
2.38%
3.08%
ROCE
1.96%
2.11%
EV
Common stock shares outstanding
925,238
881,616
950,282
Price
23.33
66.60%
14.00
-62.00%
36.85
-15.83%
Market cap
21,585,810
74.84%
12,346,149
-64.74%
35,017,879
-16.47%
EV
27,221,810
19,283,149
39,891,879
EBITDA
1,603,000
1,413,000
1,828,000
EV/EBITDA
16.98
13.65
21.82
Interest
306,000
258,000
188,000
Interest/NOPBT
71.83%
37.23%